Treace Medical Concepts, Inc. (TMCI) Q1 2024 Earnings
TMCI·Reported May 7, 2024·After market close
Treace Medical Concepts, Inc. reported Q1 2024 revenue of $51.1M, beat analyst consensus of $49.1M by $2.0M. Diluted EPS came in at $-0.30.
Revenue
$51.1Mbeat by $2.0M
Consensus: $49.1MDiluted EPS
$-0.30met estimate
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Treace Medical Concepts, Inc.'s Q1 2024 earnings report.
Treace Medical Concepts, Inc. (TMCI) reported Q1 2024 earnings on May 7, 2024 after market close.
Treace Medical Concepts, Inc. reported revenue of $51.1M and diluted EPS of $-0.30 for Q1 2024.
Revenue beat the consensus estimate of $49.1M by $2.0M. EPS beat the consensus estimate of $-0.30 by $0.00.
You can read the 10-Q periodic report (0000950170-24-054480) directly on SEC EDGAR. The filing index links above go to sec.gov.